Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-01-08		NCT05597306

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)	3
Terrence J Bradley, MD	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Miami	Miami	United States	327

Clinical trials